Primary pancreatic leiomyosarcoma is a rare mesenchymal tumour that is believed to arise from the walls of the pancreatic blood vessels or the pancreatic duct. A 56year-old female was referred with epigastric pain and abdominal mass. Preoperative computed tomography showed a large soft tissue mass in the pancreatic body and tail. Fine needle aspiration biopsy indicated a spindle cell type tumour. The patient received distal pancreatectomy with no adjuvant treatment. Histology revealed a pleomorphic spindle cell neoplasm with an immunoprofile suggestive of smooth muscle origin. The absence of other lesions in the body was consistent with the diagnosis of primary pleomorphic leiomyosarcoma. The patient was well and tumour-free 14 months after surgery. Detailed immunohistochemical analyses are necessary in the diagnosis of this highly malignant tumour. Radical resection offers the only chance of long-term survival.
Introduction
Primary leiomyosarcoma is a rare mesenchymal neoplasm of the pancreas. It accounts for only 0.1% of malignant pancreatic neoplasms, 1 and only 39 previous cases have been documented in the English language literature since 1951. 2 Imaging studies of these neoplasms may not be able to identify it specifically as a primary leiomyosarcoma and the final diagnosis needs to be based on detailed immunohistochemical analyses. To improve understanding of the clinicopathological characteristics of the lesion, a description is given here of a case of primary pancreatic pleomorphic leiomyosarcoma in a middle-aged woman who was treated by surgical resection without adjuvant therapy.
Case report
A 56-year-old female presented at the First Affiliated Hospital School of Medicine, Zhejiang University, Hangzhou, China, in December 2009, with a history of 1 month of epigastric pain, an abdominal mass and nausea. She had no medical history of sarcomas. Laboratory findings, including leucocytes, haemoglobin, platelets, serum creatinine, liver function, α-fetoprotein, carcinoembryonic antigen and cancer antigen 19-9 were all within normal limits. Abdominal ultrasonography revealed a well-Primary pancreatic pleomorphic leiomyosarcoma circumscribed hypoechoic, but not cystic, mass with heterogeneous inner echoes. A computed tomography (CT) scan demonstrated a large soft tissue mass with low-density contrast enhancement in the body and tail of the pancreas (Fig. 1A ). There was no evidence of a genital tract lesion or metastasis to the liver or lung. Gastroscopy revealed mucosal bulging of the abdomen over the stomach on external pressure. Fine needle aspiration biopsy indicated a spindle cell type tumour. Gastrointestinal stromal tumour (GIST) was considered as the initial diagnosis. A laparotomy was performed in January 2010. Exploration showed that the tumour involved the body and tail of the pancreas with direct invasion of the splenic vein, but no invasion into surrounding tissues. Consequently, distal pancreatectomy with splenectomy was performed.
Gross examination showed a solid pancreatic tumour measuring 13 × 11 × 9 cm, with a whitish cut surface and a pseudocapsule ( Fig. 1B) . Results of microscopic examination were suggestive of spindle cell neoplasm with involvement of the pancreas (Fig. 1C ). The spindle cells showed obvious pleomorphism and anisocytosis with nuclear atypias (oval, rhabdoid and bizarre nuclei) ( Fig. D) . The mitotic count was two per 10 high-power fields. Tumour necrosis was not observed, the pancreatic margins were free of tumour and lymph nodes were negative for metastasis. Immunohistochemical analyses showed that the tumour cells were positive for desmin ( Fig. 1E ), smooth muscle actin ( Fig. 1F ), vimentin ( Fig. 1G ) and H-caldesmon ( Fig.  1H ), but negative for other markers (cytokeratin, myoblast determination protein 1 [myod1], myogenin, myoglobin, HMB45 antigen, melanin A, S-100, CD68, CD34 and CD117). The immunoprofile was suggestive of pleomorphic leiomyosarcoma.
According to the French Federation of Cancer Centers Sarcoma Group system, 3 the tumour was classified as grade 2 (score 4: 3 for pleomorphic leiomyosarcoma, 1 for < 10 mitoses per 10 high-power fields and 0 for no tumour necrosis).
The patient was not given chemotherapy or radiation therapy. At 14 months after surgery she remains well and tumour-free.
Discussion
Leiomyosarcoma commonly affects the female genital tract, alimentary tract, soft tissues of the extremities and retroperitoneum, 1 but primary pancreatic leiomyosarcoma is extremely rare. To our knowledge, only 39 cases have been reported in the English language literature, 1,2,4 -28 (Table 1 ). Most cases were in elderly adult males (mean age 56.2 years, range 14 -87 years). Gender distribution was 21 males and 17 females. The chief complaints were variable: (information available in 33 cases) mainly abdominal pain (n = 20, 60.6%), weight loss (n = 11, 33.3%), jaundice (n = 7, 21.2%), nausea and vomiting (n = 5, 15.2%), palpable abdominal mass (n = 4, 12.1%), tumour detected incidentally during health examinations (n = 4, 12.1%) and distension (n = 3, 9.1%). The lesion was located in the head of the pancreas in 18 cases (52.9%), body and tail in 15 cases (44.1%) and the whole pancreas in one case (2.9%) (information available in 34 cases). Tumour size ranged from 1 to 30 cm, with a mean ± SD of 8.2 ± 5.9 cm. Treatment of the neoplasms were radical resection (22 cases), biopsy (four cases), a palliative procedure (three cases), chemotherapy only (three cases) and autopsy (one case). In several of the previous cases, primary pancreatic leiomysarcoma spread haematogenously to the liver and lung and showed adjacent organ invasion, but no lymph node Q-Y Zhang, Q-Y Shen, S Yan et al. 1, 7, 9, 12, 14, 15, 17, 25, 27 It has been proposed that pancreatic leiomysarcoma arises from the walls of the blood vessels of the pancreas or the pancreatic duct. 5 Imaging studies of the neoplasm, including ultrasonography, CT, magnetic resonance imaging and positron emission tomography-CT scanning, have found a large, circumscribed and usually hypervascular mass; however, results have sometimes been non-specific. 16, 19, 27 The final diagnoses in these previous studies were based on immunohistochemical analyses.
Primary pancreatic pleomorphic leiomyosarcoma
In the present case, the tumour was located within the anatomical boundaries of the pancreas, with a solid, nodular appearance. Complete clinical examination excluded secondary pancreatic sarcoma involvement and neither metastasis nor direct invasion of neighbouring structures was found. Immunohistochemical analyses are of great value in differentiating spindle cell tumours with marked cellular pleomorphism. Most previous studies have lacked a complete spectrum of immunohistochemical analyses, so the real percentage of primary pancreatic leiomyosarcomas might be much lower than is currently thought. The present case was positive for desmin, smooth muscle actin, vimentin and H-caldesmon, which confirmed that this tumour was a smooth muscle sarcoma. 17, 23, 27 The negative immunohistochemical reactions excluded epithelial carcinoma (cytokeratin), malignant schwannoma (S-100), malignant fibrous histiocytomas (CD68), liposarcomas (S-100), rhabdomyosarcomas (myod1, myogenin and myoglobin), GIST (CD34 and CD117), malignant haemangiopericytoma (CD34) and malignant melanoma (HMB45 antigen and melanin A). 29 Complete surgical resection offers the only chance of cure in pancreatic leiomyosarcoma.
Wide lymph node dissection is not necessary because lymphatic metastasis is not usually observed. Chemotherapy has shown a partial effect in pancreatic leiomyosarcomas. 7, 15, 24 As with other leiomyosarcomas, radiation therapy has met with minor clinical success so far. 30 Because of the rarity of reports of this tumour, there are few known criteria on which to base the prognosis for primary pancreatic leiomyosarcoma. Large tumour size is not a precise predictor of an unfavourable outcome. 27 The histological grade of malignancy could have prognostic relevance. The most reliable predictor is suggested to be the frequency of mitosis. 1 In the present case, the low mitotic count of the tumour was associated with a good outcome.
In conclusion, primary pancreatic leiomyosarcoma is an exceedingly rare but highly malignant pancreatic mesenchymal tumour. Detailed immunohistochemical analyses are of great value in the diagnosis of pancreatic leiomyosarcoma. Radical resection offers the only chance of long-term survival. The prognosis is poor and may be associated with the mitotic count.
